Overview
Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman.
Dr. Morris is highly rated in 17 conditions, according to our data. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Thyroidectomy, and Parathyroidectomy.
Her clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 8, Floor 8, Baltimore, MD 21287
10751 Falls Road, Suite 412, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David Euhus is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Euhus is highly rated in 9 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.
Skip Viragh Outpatient Cancer Center
Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is highly rated in 15 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.
Johns Hopkins Outpatient Center
Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is highly rated in 24 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Isolated HyperparathyroidismDr. Morris isDistinguished. Learn about Familial Isolated Hyperparathyroidism.
- HyperparathyroidismDr. Morris isDistinguished. Learn about Hyperparathyroidism.
- Advanced
- Anaplastic Thyroid CancerDr. Morris isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Follicular Thyroid CancerDr. Morris isAdvanced. Learn about Follicular Thyroid Cancer.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Medullary Thyroid CarcinomaDr. Morris isAdvanced. Learn about Medullary Thyroid Carcinoma.
- Neonatal Severe Hyperparathyroidism
- Osteitis FibrosaDr. Morris isAdvanced. Learn about Osteitis Fibrosa.
- Experienced
- Adrenal CancerDr. Morris isExperienced. Learn about Adrenal Cancer.
- Adrenal Gland AdenomaDr. Morris isExperienced. Learn about Adrenal Gland Adenoma.
- Adrenocortical CarcinomaDr. Morris isExperienced. Learn about Adrenocortical Carcinoma.
- CholecystitisDr. Morris isExperienced. Learn about Cholecystitis.
- CholedocholithiasisDr. Morris isExperienced. Learn about Choledocholithiasis.
- End-Stage Renal Disease (ESRD)Dr. Morris isExperienced. Learn about End-Stage Renal Disease (ESRD).